Logo Icon
OrthoLength Pro Clinical & Patient Community
Log in Register
MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

Rare Kidney Dysplasia Guide

Va
Vaqueiro Graña M, Madariaga L,...
June 26, 2025
0 views
View on PubMed
6 min read 1,136 words kidney dysplasia symptoms Medically Reviewed

Overview

Rare kidney dysplasias, such as those associated with the TFCP2L1 gene, can have a significant impact on kidney development and function. According to a recent study (Source: PubMed), a specific variant of this gene can lead to severe kidney dysfunction and salt-wasting, mimicking other conditions like Bartter syndrome. This condition affects a small number of individuals, often those with a family history of kidney disease or consanguineous relationships.

The study examined a preterm male infant with a clinical picture of advanced kidney dysfunction and severe renal salt-wasting, which was later found to be associated with a homozygous pathogenic variant in the TFCP2L1 gene. This discovery highlights the importance of genetic diagnosis in patients with refractory courses to standard treatments.

What This Study Examined

The study delved into the clinical presentation, genetic diagnosis, and management of a patient with a rare kidney dysplasia, specifically focusing on the role of the TFCP2L1 gene in kidney development and function. The researchers aimed to understand how this gene variant affects kidney function and how it can be identified and managed in clinical practice.

Why This Matters for Patients

This study matters for patients because it underscores the importance of genetic testing in the diagnosis and management of rare kidney diseases. By identifying the underlying genetic cause of their condition, patients and their families can better understand their treatment options and make informed decisions about their care. Additionally, this knowledge can help facilitate family counseling and genetic testing for relatives who may be at risk.

Medical Background

Kidney dysplasias, including those associated with the TFCP2L1 gene, are rare conditions that affect kidney development and function. Distraction osteogenesis, a process used in bone regeneration, is not directly related to kidney dysplasias but can be an important concept in understanding the principles of tissue regeneration. In the context of kidney disease, nephrology and urology are the medical specialties that focus on the diagnosis, treatment, and management of kidney and urinary tract disorders.

How the Procedure Works

Genetic testing for the TFCP2L1 gene variant involves analyzing the patient's DNA to identify any pathogenic variants. This is typically done through a blood test or a tissue sample. Once the variant is identified, the patient's treatment plan can be tailored to address their specific needs, which may include management of electrolyte imbalance, acid-base balance, and other related complications.

Who Is a Candidate?

Candidates for genetic testing for the TFCP2L1 gene variant are typically patients who present with symptoms of kidney dysfunction, such as severe polyuria, episodes of hyponatremia, hypokalemia, and hypochloremia, and whose family history or clinical presentation suggests a possible genetic underlying cause.

Clinical Summary

  • Procedure: Genetic testing for the TFCP2L1 gene variant
  • Typical Duration: several weeks to months for testing and diagnosis
  • Recovery: variable, depending on the individual's condition and treatment plan
  • Success Rate (general): high for genetic diagnosis, but variable for treatment outcomes depending on the condition and its severity

Study Methodology

The study employed a case report design, focusing on a single patient with a rare kidney dysplasia associated with the TFCP2L1 gene variant. The patient was followed up over a period, during which their clinical presentation, genetic testing, and treatment outcomes were monitored and analyzed.

Patient Selection Criteria

The patient in this study was selected based on their clinical presentation of severe kidney dysfunction and salt-wasting, which suggested a possible genetic underlying cause. The patient's family history and consanguineous relationship also supported the decision to perform genetic testing.

Outcome Measures

The study's outcome measures included the patient's clinical response to treatment, management of electrolyte and acid-base balance, and the identification of the TFCP2L1 gene variant as the underlying cause of their condition.

Results & Findings

The study found that the patient had a homozygous pathogenic variant in the TFCP2L1 gene, which was associated with their severe kidney dysfunction and salt-wasting. The patient's clinical presentation and genetic testing results supported the diagnosis of a rare kidney dysplasia.

Key Outcomes

The key outcomes of this study included the identification of the TFCP2L1 gene variant as a cause of rare kidney dysplasia, the importance of genetic testing in the diagnosis and management of this condition, and the need for tailored treatment plans to address the specific needs of patients with this condition.

Complications & Risks

Complications and risks associated with rare kidney dysplasias, including those related to the TFCP2L1 gene variant, can include severe polyuria, episodes of hyponatremia, hypokalemia, and hypochloremia, as well as metabolic alkalosis and hyperuricemia.

Key Takeaways for Patients

  • If you or a family member is experiencing symptoms of kidney dysfunction, it is essential to discuss genetic testing with your healthcare provider to determine if a rare kidney dysplasia like the one associated with the TFCP2L1 gene variant could be the underlying cause.
  • Genetic testing can help identify the underlying genetic cause of your condition, allowing for tailored treatment plans and better management of your symptoms.
  • It is crucial to work closely with your healthcare provider to manage complications and risks associated with your condition, such as electrolyte imbalances and metabolic disturbances.

When discussing your condition with your healthcare provider, be sure to ask about the following:

  • The specific genetic cause of your condition and how it affects your kidney function
  • The treatment options available to manage your symptoms and complications
  • How to monitor and manage electrolyte and acid-base balance
  • What to expect in terms of treatment outcomes and prognosis

Frequently Asked Questions

What is a kidney dysplasia?
A kidney dysplasia is a rare condition that affects kidney development and function. It can be caused by genetic mutations, such as the TFCP2L1 gene variant, and can lead to severe kidney dysfunction and related complications.
What are the symptoms of a kidney dysplasia?
Symptoms of a kidney dysplasia can include severe polyuria, episodes of hyponatremia, hypokalemia, and hypochloremia, as well as metabolic alkalosis and hyperuricemia.
How is a kidney dysplasia diagnosed?
A kidney dysplasia is typically diagnosed through a combination of clinical evaluation, laboratory tests, and genetic testing. Genetic testing can help identify the underlying genetic cause of the condition.
What are the treatment options for a kidney dysplasia?
Treatment options for a kidney dysplasia depend on the specific cause and severity of the condition. They may include management of electrolyte and acid-base balance, as well as other supportive measures to address related complications.
Can a kidney dysplasia be inherited?
Yes, some kidney dysplasias, including those associated with the TFCP2L1 gene variant, can be inherited. Family members of individuals with a kidney dysplasia may be at risk and should discuss genetic testing with their healthcare provider.
More on: kidney dysplasia symptoms Last reviewed: August 12, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Hip Dysplasia Treatment

Overview Total hip arthroplasty (THA) is a common treatment for DDH, a condition where the hip joint doesn't form properly. Patients with high dislocation due to DDH, classified as Crowe type III or IV, face significant challenges in THA, particularly in preventing nerve complications while restoring leg length. This study examined the outcomes of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy in patients with high hip dislocation. The study matters because it provides valuable insights into the treatment of DDH, a condition that affects thousands of people worldwide. According to the study, THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy can provide favorable mid-term outcomes in patients with Crowe III/IV DDH. (Source: PubMed) What This Study Examined This study examined the clinical and radiographic outcomes of primary THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy in patients with high hip dislocation. The study aimed to identify the advantages, limitations, and possible countermeasures of this surgical approach. Why This Matters for Patients This study is important for patients with high dislocation due to DDH because it provides evidence-based information on the effectiveness and safety of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy. Patients can use this information to make informed decisions about their treatment options and to discuss their concerns with their surgeons. Medical Background DDH is a condition where the hip joint doesn't form properly, leading to hip dysplasia. THA is a surgical procedure that involves replacing the damaged or arthritic hip joint with an artificial one. In patients with high dislocation due to DDH, THA can be challenging due to the risk of nerve complications and the need to restore leg length. How the Procedure Works The procedure involves using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy to replace the damaged hip joint. The osteotomy involves cutting and realigning the femur to restore leg length and improve joint mobility. The S-ROM-A modular stem is a type of prosthesis that is designed to mimic the natural movement of the hip joint. Who Is a Candidate? Patient who have high dislocation due to DDH, classified as Crowe type III or IV, may be candidates for THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy. Patients should discuss their treatment options with their surgeons to determine if this procedure is right for them. Clinical Summary Procedure: Total hip arthroplasty (THA) using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy Typical Duration: The procedure can take several hours to complete, depending on the complexity of the case Recovery: Patients can expect to spend several days in the hospital after the procedure and several weeks or months recovering at home Success Rate (general): The success rate of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy is high, with most patients experiencing significant improvements in joint mobility and functional ability Study Methodology The study was a retrospective review of patients who underwent THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy for high dislocation due to DDH. The study included 45 hips (37 patients) with a mean age of 65 years and a mean follow-up duration of 10.7 years. Patient Selection Criteria Patient were selected based on their diagnosis of high dislocation due to DDH, classified as Crowe type III or IV. Patients who underwent THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy were included in the study. Outcome Measures The study examined the clinical and radiographic outcomes of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy, including joint mobility, functional ability, and bone union at the osteotomy site. Results & Findings The study found that THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy provided favorable mid-term outcomes in patients with Crowe III/IV DDH. The study reported a low rate of complications, including no cases of postoperative infection, symptomatic pulmonary embolism, or neurological complications in the legs. Key Outcomes The study reported significant improvements in joint mobility and functional ability after THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy. The study also reported a high rate of bone union at the osteotomy site, with no cases of nonunion except for one case that required repeat surgery. Complications & Risks The study reported a low rate of complications, including early postoperative dislocation in two hips (4%) and nonunion at the osteotomy site in one hip (2%). Repeat surgery was required in only one case of nonunion. Key Takeaways for Patients THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy can provide favorable mid-term outcomes in patients with Crowe III/IV DDH Patient should discuss their treatment options with their surgeons to determine if this procedure is right for them Patient should ask their surgeons about the potential risks and benefits of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy, including the risk of nonunion and dislocation Frequently Asked Questions What is DDH? DDH is a condition where the hip joint doesn't form properly, leading to hip dysplasia. It is a common cause of hip arthritis in young adults. What is THA? THA is a surgical procedure that involves replacing the damaged or arthritic hip joint with an artificial one. It is a common treatment for DDH and other conditions that cause hip arthritis. What is an S-ROM-A modular stem? An S-ROM-A modular stem is a type of prosthesis that is designed to mimic the natural movement of the hip joint. It is used in THA to replace the damaged or arthritic hip joint. What is oblique subtrochanteric shortening osteotomy? Oblique subtrochanteric shortening osteotomy is a surgical procedure that involves cutting and realigning the femur to restore leg length and improve joint mobility. What are the potential risks and benefits of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy? The potential benefits of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy include significant improvements in joint mobility and functional ability. The potential risks include nonunion and dislocation. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Limb Lengthening for Fibrous Dysplasia

OverviewFibrous dysplasia is a rare condition that can cause bone deformity, leading to severe antibowing of the tibia, also known as saber-shin deformity. This condition can result in significant limb-length discrepancy and bone pain. A recent study published on PubMed (Source: PubMed) demonstrated the successful use of limb lengthening using an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia.The study examined the use of asymmetric lengthening to achieve simultaneous angular realignment and limb-length restoration in an adult patient with a severe saber-shin deformity. This approach is particularly significant in resource-limited settings where more advanced technologies, such as the Taylor Spatial Frame, may not be available.Fibrous dysplasia affects approximately 1 in 4,000 to 1 in 10,000 people, and severe anterior tibial bowing is a rare but challenging complication of this condition. Patients with this condition often experience significant bone pain, limb-length discrepancy, and mobility issues.What This Study ExaminedThis study examined the use of an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia. The study demonstrated the effectiveness of asymmetric lengthening in achieving simultaneous angular realignment and limb-length restoration in an adult patient.Why This Matters for PatientsThis study is significant for patients with fibrous dysplasia who are experiencing severe anterior tibial bowing and limb-length discrepancy. The use of an Ilizarov ring fixator and asymmetric lengthening provides a practical and low-cost alternative for complex deformity correction in resource-limited settings.Medical BackgroundFibrous dysplasia is a rare condition that can cause bone deformity, leading to severe antibowing of the tibia, also known as saber-shin deformity. This condition can result in significant limb-length discrepancy and bone pain. Limb lengthening using an Ilizarov ring fixator is a surgical procedure that involves cutting and lengthening the bone to correct bone deformity and achieve limb-length restoration.Limb lengthening is a complex procedure that requires careful planning and execution. The procedure involves the use of an external fixator, such as an Ilizarov ring fixator, to stabilize and lengthen the bone. The osteotomy is performed, and the bone is gradually lengthened using a process called distraction osteogenesis.How the Procedure WorksThe limb lengthening procedure involves several steps. First, the osteotomy is performed, and the bone is cut and prepared for lengthening. The Ilizarov ring fixator is then applied, and the bone is gradually lengthened using distraction osteogenesis. This process can take several months to complete, and the patient must undergo regular follow-up appointments to monitor the progress of the lengthening.Who Is a Candidate?Patients with severe anterior tibial bowing secondary to fibrous dysplasia may be candidates for limb lengthening using an Ilizarov ring fixator. The procedure is typically recommended for patients who have significant limb-length discrepancy and bone pain that is not responsive to conservative treatment. Patients must be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program to achieve optimal results.Clinical SummaryProcedure: Limb lengthening using an Ilizarov ring fixatorTypical Duration: Several months to complete the lengthening processRecovery: Prolonged period of rehabilitation and follow-up appointments to monitor the progress of the lengtheningSuccess Rate (general): High success rate for achieving significant limb-length restoration and correcting bone deformityStudy MethodologyThe study was a case report that examined the use of an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia in an adult patient. The patient underwent two tibial osteotomies proximal and distal to the apex of the deformity, and an Ilizarov ring construct was applied without hinge mechanisms. The patient underwent progressive adjustment of the Ilizarov ring fixator to achieve satisfactory angular realignment and near-complete limb-length restoration.Patient Selection CriteriaThe patient was selected for the study based on the presence of severe anterior tibial bowing secondary to fibrous dysplasia and significant limb-length discrepancy. The patient was also required to be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program.Outcome MeasuresThe outcome measures for the study included the degree of angular realignment and limb-length restoration achieved, as well as the presence of any complications or adverse events. The patient was followed up for a period of several months to monitor the progress of the lengthening and to assess the final outcome.Results & FindingsThe study demonstrated the successful use of an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia in an adult patient. The patient achieved satisfactory angular realignment and near-complete limb-length restoration, with a significant reduction in bone pain and improvement in mobility.Key OutcomesThe key outcomes of the study included the degree of angular realignment and limb-length restoration achieved, as well as the presence of any complications or adverse events. The patient experienced no significant complications or adverse events during the study period, and the final outcome was considered to be excellent.Complications & RisksAs with any surgical procedure, there are potential complications and risks associated with limb lengthening using an Ilizarov ring fixator. These may include osteomyelitis, neurological damage, and malunion or nonunion of the osteotomy site. Patients must be carefully selected and monitored to minimize the risk of these complications.Key Takeaways for PatientsPatient with severe anterior tibial bowing secondary to fibrous dysplasia may be candidates for limb lengthening using an Ilizarov ring fixatorThe procedure can achieve significant limb-length restoration and correction of bone deformityPatients must be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program to achieve optimal resultsPatients should ask their surgeon about the potential risks and complications of the procedure, as well as the expected outcome and rehabilitation requirementsPatient should also ask their surgeon about the following:What is the expected duration of the distraction osteogenesis process?What are the potential risks and complications of the procedure?What is the expected outcome and how will it be measured?What is the rehabilitation program and how long will it last?Frequently Asked QuestionsWhat is fibrous dysplasia?Fibrous dysplasia is a rare condition that can cause bone deformity, leading to severe antibowing of the tibia, also known as saber-shin deformity. It is a genetic disorder that affects the development of the bone and can cause a range of symptoms, including bone pain, limb-length discrepancy, and mobility issues.What is limb lengthening?Limb lengthening is a surgical procedure that involves cutting and lengthening the bone to correct bone deformity and achieve limb-length restoration. It is typically performed using an external fixator, such as an Ilizarov ring fixator, to stabilize and lengthen the bone.What is an Ilizarov ring fixator?An Ilizarov ring fixator is a type of external fixator that is used to stabilize and lengthen the bone during limb lengthening. It is a circular device that is attached to the bone using wires and pins, and is used to apply a gradual and controlled force to the bone to achieve limb-length restoration and correction of bone deformity.What are the potential risks and complications of limb lengthening?As with any surgical procedure, there are potential risks and complications associated with limb lengthening. These may include osteomyelitis, neurological damage, and malunion or nonunion of the osteotomy site. Patients must be carefully selected and monitored to minimize the risk of these complications.How long does the distraction osteogenesis process take?The distraction osteogenesis process can take several months to complete, depending on the degree of limb-length restoration required and the individual patient's response to the procedure. Patients must be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program to achieve optimal results.What is the rehabilitation program like after limb lengthening?The rehabilitation program after limb lengthening is typically rigorous and requires a significant amount of time and effort from the patient. Patients must undergo regular physical therapy sessions to maintain range of motion and strength in the affected limb, and must also follow a strict program of rehabilitation exercises to achieve optimal results. The rehabilitation program can last for several months to a year or more, depending on the individual patient's needs and response to the procedure. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks Advancements in Hip Surgery: A Comprehensive Guide for Patients Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy

Read Full Summary →
Clinical Insight

Canine Femoral Trochlear Dysplasia and Dejour Signs: Clinical Relevance of Radiographs and Computed Tomography

Overview Recent research has shown that the radiographic patterns first described in human knee dysplasia—known as Dejour signs—can also be identified in dogs with patellar luxation (PL). The study titled “Canine Femoral Trochlear Dysplasia: A Retrospective Study Assessing the Dejour Signs” evaluated whether these classic imaging markers are present in healthy dogs versus dogs that suffer from PL, and whether modern computed tomography (CT) can replace traditional mediolateral radiographs for diagnosis (Source: PubMed / Europe PMC). Understanding these findings helps veterinarians and pet owners make more informed decisions about surgical planning and postoperative expectations. Patellar luxation is a common orthopedic problem in small‑breed dogs, often resulting in pain, lameness, and reduced quality of life. Accurate identification of femoral trochlear dysplasia influences the choice of surgical technique—whether to deepen the groove, realign the extensor mechanism, or perform a tibial plateau leveling osteotomy. By confirming that Dejour signs are both present and reliably visualized on CT, the study offers clinicians a modern, three‑dimensional tool that may improve pre‑operative planning and ultimately lead to better outcomes for dogs and their families. Medical Background Femoral trochlear dysplasia refers to an abnormal shape of the femoral trochlea—the cradle‑like groove at the end of the femur that guides the patella (kneecap) during movement. When the groove is too shallow, flat, or even convex, the patella can slip out of place, a condition called patellar luxation (PL). In dogs, PL is most often seen in toy and small breeds such as Maltese, Pomeranians, and Miniature Pinschers. The Dejour classification—originally created for human patients—identifies three radiographic landmarks that signal trochlear dysplasia: Crossing sign: the trochlear sulcus line crosses the distal femoral condyle, indicating a reduced trochlear depth. Supratrochlear spur: a bony prominence above the trochlear groove. Double‑contour sign: a duplicated outline of the trochlear articular surface, reflecting a flattened or dysplastic groove. These signs help surgeons decide whether a simple realignment is sufficient or whether a trochleoplasty (groove‑deepening) is required. The newly described “dome sign” reflects a convex trochlear surface on a single projection line and may correlate with more severe (grade‑4) PL. How the Procedure Works Standard diagnostic work‑up for a dog suspected of PL includes a physical examination, measurement of the quadriceps angle, and imaging of the stifle joint. Traditionally, a mediolateral radiograph is taken with the knee flexed to 30‑40° to best display the trochlear groove. The advent of CT scanners has allowed clinicians to reconstruct a true lateral view from volumetric data, eliminating superimposition of other bony structures and providing a clearer view of the trochlear morphology. Study Methodology The investigation was a retrospective case‑control study conducted at a single veterinary teaching hospital between 2015 and 2022. The authors screened hospital records for dogs that had undergone both mediolateral stifle radiographs and a CT scan of the same joint for any reason (e.g., pre‑operative planning, trauma assessment). Inclusion criteria were: Age between 6 months and 8 years. Availability of high‑quality mediolateral radiographs taken with the stifle flexed to 30°–40°. A CT study that included the distal femur and proximal tibia with slice thickness ≤1 mm. Clear documentation of patellar status (either normal or luxated) confirmed by orthopaedic examination. Forty femoral trochleae met these criteria and were divided into two groups: Control group: 15 dogs without any evidence of patellar instability (n = 15 trochleae). PL group: 25 dogs diagnosed with unilateral or bilateral patellar luxation (n = 25 trochleae). Within this group, luxation severity was graded according to the established 4‑grade system, where grade 4 represents the most severe and chronic displacement. All imaging studies were anonymized and randomised. A single board‑certified radiologist, blinded to the clinical status of each specimen, reviewed each image set for the presence of the three classic Dejour signs (crossing, supratrochlear spur, double‑contour) and for the newly proposed dome sign. The radiologist recorded each sign as present or absent, resulting in a binary outcome for each feature. Statistical analysis employed Cohen’s kappa (κ) to assess inter‑modality agreement (radiograph vs. CT) and McNemar’s test to examine differences in detection rates between the two imaging techniques. A p‑value  0.05), indicating that CT lateral reconstructions are interchangeable with conventional radiographs for identifying these dysplastic features. Importantly, the dome sign was consistently identified on both radiographs and CT in the same 24 % of PL cases, predominantly in dogs classified as grade‑4 luxation (5 out of 6 dome‑sign positive knees). This suggests a possible correlation between severe patellar displacement and a convex trochlear morphology. Clinical Implications These findings have several practical ramifications for veterinarians, orthopedic surgeons, and pet owners: Diagnostic confidence: The presence of any Dejour sign should raise suspicion for underlying femoral trochlear dysplasia, prompting a more thorough pre‑operative work‑up. Because the signs are rare in normal dogs, false‑positive rates are low. Imaging choice: CT offers a three‑dimensional assessment without the superimposition inherent to plain radiographs, yet the study demonstrates that CT lateral reconstructions detect Dejour signs with comparable accuracy. Consequently, clinicians can select the modality that best fits their practice logistics and the patient’s anesthesia status. Surgical planning: When one or more Dejour signs are present, especially in combination, surgeons may consider a trochleoplasty in addition to tibial tuberosity advancement or tibial plateau leveling osteotomy. The identification of a dome sign may further signal the need for groove deepening because a convex trochlea provides minimal bony restraint for the patella. Prognostic value: The association between the dome sign and grade‑4 PL suggests that dogs with this radiographic marker could have a more guarded postoperative outcome, necessitating closer follow‑up and potentially a more aggressive rehabilitation protocol. Owner communication: Veterinarians can use the visual evidence of Dejour signs to explain the anatomical basis of the disease to pet owners, fostering realistic expectations regarding surgery, recovery time, and the possibility of recurrence. In summary, recognizing Dejour signs and the dome sign on either radiographs or CT provides a reliable, objective method for assessing femoral trochlear dysplasia in dogs with PL. This enhances the surgeon’s ability to tailor the operative technique to the individual anatomy, which may reduce the incidence of postoperative luxation recurrence and improve long‑term limb function. Frequently Asked Questions Q: What are Dejour signs and why do they matter in dogs? A: Dejour signs are three specific radiographic markers—crossing sign, supratrochlear spur, and double‑contour sign—that indicate an abnormal shape of the femoral trochlea. Their presence suggests trochlear dysplasia, a key factor in patellar luxation, and helps the surgeon decide whether additional procedures like trochleoplasty are needed. Q: Can a plain radiograph miss a Dejour sign that a CT would detect? A: In this study, detection rates were statistically equivalent between the two modalities. However, CT eliminates overlap of adjacent bones and can provide a clearer view in cases where positioning is suboptimal, so it may be preferred in borderline or complex cases. Q: What is the “dome sign” and how should it influence treatment? A: The dome sign is a single‑line projection indicating a convex trochlear surface. It was observed in 24 % of PL‑affected knees, most often in grade‑4 luxations. Its presence may signal a more severe dysplasia, prompting the surgeon to consider a deeper trochlear groove correction. Q: Should every dog with patellar luxation undergo CT scanning? A: Routine CT is not mandatory, but it is advisable when the radiographs are inconclusive, when the dog is already under general anesthesia for another procedure, or when detailed three‑dimensional planning is required (e.g., combined tibial plateau leveling osteotomy and trochleoplasty). Q: Does the presence of Dejour signs predict a higher chance of surgical failure? A: While the study did not follow postoperative outcomes, other literature suggests that unaddressed trochlear dysplasia can lead to recurrence of luxation. Identifying Dejour signs pre‑operatively allows the surgeon to modify the technique, which is thought to reduce failure rates. For veterinarians and pet owners alike, the integration of Dejour sign assessment into standard diagnostic protocols represents a step forward in the evidence‑based management of patellar luxation—a condition that, when properly addressed, can return a dog to pain‑free activity and an improved quality of life. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Femoral Fracture & Kidney Injury

Overview Femoral fractures, a common type of bone fracture, can have significant consequences on the body, particularly in regards to kidney function. Recent research has shed light on the relationship between femoral fractures and TRAKI, highlighting the importance of understanding the underlying mechanisms. This study, published in Bone Joint Res (Source: PubMed / Europe PMC), investigated the impact of femoral shaft fractures on kidney function in mice, revealing valuable insights for patients and medical professionals alike. The study's findings are particularly relevant for individuals who have suffered from high-energy trauma, such as car accidents or falls, which can result in femoral fractures. As the population ages, the incidence of osteoporosis and osteopenia increases, making older adults more susceptible to fractures. Furthermore, patients with pre-existing kidney disease may be at higher risk of developing AKI following a femoral fracture. What This Study Examined This study examined the effects of femoral fracture on kidney function in mice, with a focus on the role of adrenergic receptors in the development of TRAKI. The researchers used a combination of blood urea nitrogen measurement, histology, and gene expression analysis to assess kidney damage and function. Why This Matters for Patients Understanding the relationship between femoral fractures and kidney function is crucial for patients, as it can inform treatment decisions and improve outcomes. The study's findings suggest that patients with femoral fractures may be at risk of developing transient AKI, which can have significant consequences if left untreated. By recognizing the potential for kidney damage, medical professionals can take proactive steps to monitor and manage kidney function, ultimately improving patient outcomes. Medical Background A femoral fracture is a type of bone fracture that occurs in the femur, the longest bone in the body. This type of fracture can be caused by high-energy trauma, such as a car accident or fall, and can have significant consequences on the body. Distraction osteogenesis and osteotomy are sometimes used to treat femoral fractures, particularly in cases where limb lengthening is necessary. How the Procedure Works The treatment of femoral fractures typically involves surgical stabilization using an external fixator or intramedullary nail. In some cases, callotasis may be used to promote bone regeneration. Who Is a Candidate? Patients who have suffered a femoral fracture may be candidates for surgical treatment, particularly if they have experienced significant bone displacement or instability. The decision to undergo surgery will depend on various factors, including the severity of the fracture, the patient's overall health, and their medical history. Clinical Summary Procedure: Femoral fracture treatment, which may involve surgical stabilization using an external fixator or intramedullary nail. Typical Duration: The duration of treatment will vary depending on the severity of the fracture and the patient's overall health, but typically ranges from several weeks to several months. Recovery: Recovery from a femoral fracture can take several months, during which time patients may need to use assistance devices to mobilize. Success Rate (general): The success rate of femoral fracture treatment is generally high, but will depend on various factors, including the severity of the fracture and the patient's overall health. Study Methodology The study used a controlled laboratory setting to investigate the effects of femoral fracture on kidney function in mice. A total of 46 female C57BL/6J mice were subjected to femoral shaft fracture and external fixation, and received daily treatment for three days with either phentolamine, propranolol, or butoxamine. Patient Selection Criteria The study used a controlled laboratory setting, and the mice were randomly assigned to receive one of three treatments. The mice were then analyzed at two time points: early (at day 1) and late (at day 21) post-fracture. Outcome Measures The study used a combination of outcome measures to assess kidney damage and function, including blood urea nitrogen measurement, histology, and gene expression analysis. Results & Findings The study found that femoral fractures can induce transient AKI in mice, characterized by increased expression of kidney damage markers and oxidative stress indicators. The study also found that adrenergic receptor blockade can modulate the kidneys' response to oxidative stress. Key Outcomes The study's key outcomes include the finding that femoral fractures can induce transient AKI in mice, and that adrenergic receptor blockade can modulate the kidneys' response to oxidative stress. Complications & Risks The study found that femoral fractures can induce transient AKI in mice, which can have significant consequences if left untreated. The study also found that adrenergic receptor blockade can modulate the kidneys' response to oxidative stress, but may also have side effects. Key Takeaways for Patients Patient education is key: patients should be aware of the potential risks of AKI following a femoral fracture. Monitoring kidney function is crucial: patients should have their kidney function monitored regularly following a femoral fracture. Treatment options are available: patients with femoral fractures may be candidates for surgical treatment, and should discuss their options with their healthcare provider. Adrenergic receptor blockade may be beneficial: adrenergic receptor blockade may be beneficial in modulating the kidneys' response to oxidative stress. Patients should ask their surgeon about the potential risks of AKI following a femoral fracture, and what steps can be taken to monitor and manage kidney function. Frequently Asked Questions What is a femoral fracture? A femoral fracture is a type of bone fracture that occurs in the femur, the longest bone in the body. This type of fracture can be caused by high-energy trauma, such as a car accident or fall, and can have significant consequences on the body. What are the symptoms of a femoral fracture? The symptoms of a femoral fracture may include pain, swelling, and deformity of the affected leg. Patients may also experience limited mobility and numbness or tingling in the affected leg. How is a femoral fracture treated? A femoral fracture is typically treated with surgical stabilization using an external fixator or intramedullary nail. In some cases, distraction osteogenesis or osteotomy may be used to promote bone regeneration. What are the risks of a femoral fracture? The risks of a femoral fracture include infection, nerve damage, and blood clots. Patients with femoral fractures may also be at risk of developing AKI, which can have significant consequences if left untreated. How can I prevent a femoral fracture? While it is not always possible to prevent a femoral fracture, patients can take steps to reduce their risk of osteoporosis and osteopenia, such as maintaining a healthy diet, exercising regularly, and avoiding smoking. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →